They Said “2–3 Months to Live” — 10 Years Later, He's Thriving | Dr. Dino Prato

They Said “2–3 Months to Live” — 10 Years Later, He's Thriving | Dr. Dino Prato

Author: Dr. Dino Prato - Envita Medical Centers April 22, 2026 Duration: 16:04
This episode explores challenging medical prognoses, from inoperable tumors to dire timelines, highlighting the critical need for advanced patient care. Dr. Prato discusses how precise oncology approaches can offer hope, even when traditional healthcare options seem limited. By focusing on personalized cancer treatment, we aim to redefine what's possible for every cancer patient. 🎯 What You’ll Learn in This Episode: • What “2–3 months to live” typically means clinically • Why cancer varies ...

For anyone navigating a cancer diagnosis, the standard treatment path can feel both overwhelming and impersonal. OutSmart Cancer-Precision Oncology. Less Guess Work. More Life! moves beyond that generic approach, diving into the nuanced world of personalized medicine. Hosted by Dr. Dino Prato, founder of Envita Medical Centers, conversations here are built on a quarter-century of clinical experience helping patients for whom conventional protocols weren't enough. You'll hear detailed discussions that demystify complex topics like genomic testing, targeted therapies, and how integrative strategies can support the body during treatment. This isn't about promoting easy answers; it's about exploring the detailed, often overlooked factors that influence cancer progression and recovery. Each episode aims to translate cutting-edge science and hard-earned clinical wisdom into actionable knowledge, empowering you and your loved ones to ask better questions and understand the full spectrum of options. Tune in for a resource that treats your journey with the specificity it deserves, fostering informed dialogue between patients and their healthcare teams. This podcast serves as a guide for those determined to look deeper into their care, emphasizing a strategy tailored to the individual rather than the disease alone.
Author: Language: en-us Episodes: 100

OutSmart Cancer - Precision Oncology. Less Guess Work. More Life!
Podcast Episodes
The Real Reason Cancer Comes Back Even After Remission [not-audio_url] [/not-audio_url]

Duration: 9:06
Cancer recurrence often stems from dormant cancer cells, not just the primary tumor. These "sleeper cells" can reawaken years later, leading to metastasis. This video presents a smarter approach to cancer treatment, focu…
Blood Cancer Recurrence Isn't Treatment Failure—It's This [not-audio_url] [/not-audio_url]

Duration: 11:36
This video explains why blood cancer can recur, often due to minimal residual disease (MRD) that goes undetected despite initial treatment success. We discuss how initial improvements in scans and blood counts can be mis…
When Standard Immunotherapy Doesn't Work, Try This Instead [not-audio_url] [/not-audio_url]

Duration: 18:55
In this episode, Dr. Dino Prato navigates the complexities of treating cancers that appear invisible to the immune system, making traditional immunotherapy for cancer less effective. He explains how building custom immun…
Cancer Patients Are Told to Eat Anything | That's Killing Them [not-audio_url] [/not-audio_url]

Duration: 12:38
This video clarifies why the common advice to "eat whatever you want" during cancer treatment is misleading, emphasizing that food provides crucial signaling for your body. We explore how nutrition impacts your immune sy…
Anktiva | Cancer Immune Stimulation Isn't Enough Without This? [not-audio_url] [/not-audio_url]

Duration: 21:19
Anktiva is an exciting new cancer immunotherapy that helps the immune system fight and kill cancer cells. Doctors believe it could support treatment for many cancers when used in the right personalized combinations — but…
Can Cancer Spread From a Biopsy? Here's What Research Says [not-audio_url] [/not-audio_url]

Duration: 11:23
This video addresses a common patient fear: whether a biopsy might lead to cancer spread. We provide honest data and health education, explaining that while biopsy-related seeding is real, the information gained through…